Intellipharmaceutics International is a biotechnology business based in Canada. Intellipharmaceutics International shares (IPCI) are listed on the Toronto Stock Exchange (TSX) and all prices are listed in Canadian Dollars. Intellipharmaceutics International employs 11 staff and has a trailing 12-month revenue of around C$904,946.
Our top picks for where to buy Intellipharmaceutics International stock
How to buy Intellipharmaceutics International stock
- Choose a stock trading platform. Compare investment platforms.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – IPCI. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Intellipharmaceutics International stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Finder Score for stock trading platforms
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.
Intellipharmaceutics International stock price (Toronto Stock Exchange (TSX): IPCI)
Use our graph to track the performance of IPCI stocks over time.Intellipharmaceutics International stocks at a glance
52-week range | C$0.07 - C$0.10 |
---|---|
50-day moving average | C$0.08 |
200-day moving average | C$0.09 |
Wall St. target price | C$2.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | C$-0.12 |
Is it a good time to buy Intellipharmaceutics International stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Intellipharmaceutics International financials
Revenue TTM | C$904,946 |
---|---|
Gross profit TTM | C$65,728 |
Return on assets TTM | -107.39% |
Return on equity TTM | 0% |
Profit margin | 0% |
Book value | C$-0.39 |
Market Capitalization | C$2.6 million |
EBITDA | C$-2,407,400 |
TTM: trailing 12 months
Intellipharmaceutics International stock dividends
We're not expecting Intellipharmaceutics International to pay a dividend over the next 12 months.
Have Intellipharmaceutics International's stocks ever split?
Intellipharmaceutics International's stocks were split on a 1:10 basis on 13 September 2018 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Intellipharmaceutics International stocks – just the quantity. However, indirectly, the new 900% higher stock price could have impacted the market appetite for Intellipharmaceutics International stocks, which in turn could have impacted Intellipharmaceutics International's stock price.
Intellipharmaceutics International stock price volatility
Over the last 12 months, Intellipharmaceutics International's stocks have ranged in value from as little as C$0.07 up to C$0.1. A popular way to gauge a stock's volatility is its "beta."
Beta is a measure of a stocks volatility in relation to the market. The market (TO average) beta is 1, while Intellipharmaceutics International's is 0.294. This would suggest that Intellipharmaceutics International's stocks are less volatile than average (for this exchange).
Intellipharmaceutics International overview
Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for hyperactivity disorder; Keppra XR, a levetiracetam extended-release tablet for the treatment of partial onset seizures in patients with epilepsy; Effexor XR, a venlafaxine hydrochloride extended-release capsule to treat depression; and Protonix, a pantoprazole sodium delayed-release tablet to treat gastroesophageal reflux disease. In addition, it provides Glucophage XR, a metformin hydrochloride extended-release tablet that treats type 2 diabetes; Seroquel XR, a quetiapine fumarate extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorders; Lamictal XR, a lamotrigine extended release tablet to treat epilepsy; Pristiq, a desvenlafaxine extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; and Ranexa, a ranolazine extended release tablet for chronic angina. Further, the company is developing OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Regabatin XR, a pregabalin extended-release capsule for the management of neuropathic pain. It has a license and commercialization agreement with Par Pharmaceutical Inc.
Frequently asked questions
What percentage of Intellipharmaceutics International is owned by insiders?Currently 1.757% of Intellipharmaceutics International stocks are held by insiders. How many people work for Intellipharmaceutics International?
Latest data suggests 11 work at Intellipharmaceutics International. When does the fiscal year end for Intellipharmaceutics International?
Intellipharmaceutics International's fiscal year ends in November. Where is Intellipharmaceutics International based?
Intellipharmaceutics International's address is: 30 Worcester Road, Toronto, ON, Canada, M9W 5X2 What is Intellipharmaceutics International's ISIN number?
Intellipharmaceutics International's international securities identification number is: CA4581733090
More on investing

Meme stocks: What they are and examples of popular stocks
Meme stocks can produce large gains in short periods, but the stocks are volatile.
Read more…
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…More guides on Finder
-
Best renewable energy stocks
These are the best renewable energy stocks to buy now in Canada.
-
Best stocks to buy right now in Canada
Finder’s unique algorithm found the 20 best TSX stocks to buy right now.
-
5 Best ETFs in Canada for 2025
Looing for the best performing ETF in Canada? Explore the best Canadian ETFs on the TSX for dividend, REIT, bond investing and more.
-
4 Best US ETFs for 2025
Looing for the best US ETF? Explore the best US ETFs, including top US dividend and Nasdaq funds.
-
10 best stock trading platforms and apps in Canada for 2025
Whether you’re a new or experienced investor, these are the best stock trading platforms and apps in Canada.
-
How to buy US stocks in Canada
Buying US stocks in Canada is easier than you think. Find out how to buy US stocks in 4 simple steps.
-
How to invest in the S&P 500 in Canada
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.
-
BMO InvestorLine review
Check out the pros and cons of BMO’s self-directed trading platform in our InvestorLine review.
-
How to trade options in Canada
What is options trading and are options better than stocks? Learn how options trading in Canada works.
-
How to buy stocks in Canada
Want to know how to buy and sell stocks in Canada? Find out what you need to know in this simple, step-by-step guide.